Monroe
Walton Park
Your Local News for Monroe and Walton Park, New York
Subscribe
Subscribe
Sunday, jun 14
79°
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Monroe
Walton Park
Subscribe
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2026 Cantata Media
79°
Sunday, jun 14
News
Covid-
19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines
Call it a COVID-19 combo pack. A New England man is telling his story after a mixup led to him getting one dose each of the Moderna and Pfizer COVID-19 vaccines. New Hampshire resident Craig Richards quickly noticed on Tuesday, April 13 that the second dose he had just received was a Pfizer shot. His first dose had been the Moderna vaccine. "As soon as he poked me, he looked down at my card, and I think he realized he just gave me the Pfizer," Richards told ABC-TV affiliated WMUR of Manchester, New Hampshire. A supervisor at the site, the same place Richards received his first dose, …
News
Covid-
19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…
News
Covid-
19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose
Pfizer CEO Albert Bourla is cautioning that patients will likely need a third dose of the company’s COVID-19 vaccine within the next year to maintain the shot’s efficacy. During a recently aired interview, Bourla said that patients will “likely” need an additional dose of the vaccine within 12 months of becoming fully vaccinated with the two required doses. Bourla said that they are continuing to monitor the situation, and as more COVID-19 variants arise, the company may be forced to shift gears. “We need to see what would be the sequence, and for how often we need to do that, that remains…
Business
Covid-
19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says
The one-dose Johnson & Johnson COVID-19 vaccine has proven efficient in getting the needles in as many Americans’ arms as possible, but some are reporting debilitating side effects after receiving their shot. Recently, some have come forward with severe symptoms after being administered the COVID-19 vaccine, prompting some health officials to issue warnings and the FDA to press pause on distributing new allocations to pharmacies and healthcare providers across the country. Earlier story - CDC, FDA Call For Pause On Johnson & Johnson Vaccine Symptoms include a severe, persisting hea…
News
Covid-
19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months
The Moderna COVID-19 vaccine loses a bit of its effectiveness after six months, though not as much as originally thought, according to the latest trial conducted by the pharmaceutical company. Moderna found in its latest trial that its COVID-19 vaccine maintains at least 90 percent of its efficacy in battling the virus after six months. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients Researchers said the latest data evaluated 33 adults who participated in Phase 1 of Moderna’s vaccine study, which found the antibodies pers…
Business
Covid-
19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines
Hundreds of millions of new COVID-19 vaccines are set to be distributed across the country as Pfizer prepares to ramp up the production of its doses amid the pause of the Johnson & Johnson one-dose shot rollout. Pfizer CEO Albert Bourla announced that his company, with headquarters in the New York (in Manhattan and Rockland County), is now on track to deliver 10 percent more vaccine doses to the US (approximately 220 million) while supplying the already agreed upon 300 million doses for the end of July two weeks early. Both Pfizer and Moderna, two of the three approved vaccines by the F…
Lifestyle
Covid-
19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated
Are you Team Moderna or Team Pfizer? A good-natured rivalry has been brewing between those receiving the Moderna COVID-19 vaccine versus the Pfizer vaccine as more doses have been made available to the majority of the public. Since Americans began receiving their initial doses of the two-shot Moderna and Pfizer vaccines, photos of vaccination cards and celebratory videos of successful shots have flooded social media, with some on both sides taking playful jabs at the other in the process. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Va…
News
Covid-
19: Second-Dose Skipping Sparks Concern Among Medical Experts
Though millions of COVID-19 vaccines are being administered daily in the United States, some medical experts are now concerned about some eager Americans going to get their first dose and then skipping out on the second out of complacency. Some are citing side effects that come with the second dose of the two-shot Moderna and Pfizer vaccines, which has increased “vaccine-hesitancy” and has some not heading back to their healthcare provider to complete the vaccination process. Others have simply missed appointments or opted against going back to receive a second dose. However, health of…
News
Covid-
19: Pfizer Seeks FDA Approval To Give Vaccines To Kids In New Age Group
Pfizer is seeking federal approval to expand the use of its COVID-19 vaccine in adolescents between the ages of 12 and 15. The company announced that it is asking the Food and Drug Administration to amend its emergency use authorization, which was granted for people ages 16 and up late last year. Now, Pfizer is looking to expand its usage to adolescents as they work to get students back to full in-person learning for the fall semester. Clinical trials of the Pfizer/BioNTech’s COVID-19 vaccine have shown that it has a 100 percent efficacy in adolescents and is well-tolerated in minors betw…
News
Covid-
19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients
Those who have taken the Moderna COVID-19 vaccine are reporting more side effects than those who got a dose from Pfizer, according to a new study. Using data from more than three million vaccine recipients collected from the Centers for Disease Control and Prevention (CDC), it was determined that nearly 70 percent of those studied reported minor side effects such as fatigue or chills. Of those reporting side effects, the researchers found that more participants impacted had received the Moderna vaccine compared to the Pfizer vaccine. According to the study, 73 percent of those who got the…
Schools
Covid-
19: SUNY To Provide One-Shot J&J Vaccine To Students Before Summer Break
The State University of New York school system will be making the one-dose Johnson & Johnson vaccine available to students before they head home for Summer Break with the intention of fully reopening campuses in the fall. With eligibility for the COVID-19 vaccine expanding to all New Yorkers 16 and older on Tuesday, April 6, SUNY Chancellor Jim Malatras announced that thousands of the Johnson & Johnson vaccines were being distributed to the 34 SUNY campuses. The latest measure comes on the hells of Malatras announcing SUNY’s intention to fully reopen for in-person learning across th…
News
Covid-
19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective
The Moderna COVID-19 vaccine could provide protection against the virus for a minimum of a half a year, according to a new report published this week. A report in the New England Journal of Medicine was published this week advising that the Moderna vaccine, much like its counterpart from Pfizer, will remain effective against COVID-19 for at least six months once both doses are administered. The latest report comes after dozens of tests of those who received the shot during the study. With this research, using three separate tests that look for antibodies, the scientists found that pr…
Next Page
Archive
79°
